Effects of the Tobacco Defensin NaD1 Against Susceptible and Resistant Strains of Candida albicans
Olga V Shevchenko, Alexander D Voropaev, Ivan V Bogdanov, Tatiana V Ovchinnikova, Ekaterina I Finkina, Tomasz M Karpiński, Marcin Ożarowski · 2024
Read Effects of the Tobacco Defensin NaD1 Against Susceptible and Resistant Strains of Candida albicans by Olga V Shevchenko, Alexander D Voropaev, Ivan V Bogdanov, Tatiana V Ovchinnikova, Ekaterina I Finkina, Tomasz M Karpiński, Marcin Ożarowski (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11678012.txt.
Description
Olga Shevchenko, Alexander Voropaev, Ivan Bogdanov, Tatiana Ovchinnikova, Ekaterina Finkina, and two colleagues test a plant peptide against drug-resistant yeast in this two thousand twenty-four paper. Candida albicans is the top cause of local and life-threatening body-wide candidiasis, and resistant strains are spreading. The tobacco defensin NaD1 killed every tested strain, open to or resistant to azoles and echinocandins, at the same low doses, and it killed rather than merely slowing growth.
The peptide worked in combination. It teamed with the drug caspofungin and, reported for the first time, with human defense peptides LL-37 and beta-defensin-2, the mixes disrupting fungal membranes more than either partner alone. In a human gut cell model, NaD1 reduced Candida sticking to the lining. It blocked biofilm formation and strengthened the antibiofilm action of caspofungin. The authors propose NaD1 as a candidate against candidiasis, including infections from resistant strains.
Catalog record
| CREATOR | Olga V Shevchenko, Alexander D Voropaev, Ivan V Bogdanov, Tatiana V Ovchinnikova, Ekaterina I Finkina, Tomasz M Karpiński, Marcin Ożarowski |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 60 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |